Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal Cancer

Clinical trial NCT04177875 · UNKNOWN

Trial details

NCT number: NCT04177875
Sponsor: Tongji Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophagus Cancer

Start date: 2019-05-01
Primary completion: 2021-04-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.